DXCMDexcom
$79.41+16% 1Y
$79.41
$54.8452 weeks$92.35
Valuation
What DXCM's price assumes
Dexcom trades at 31.3× earnings against 26.7× for the median Medical Devices name.
31.3
Trailing P/E · Medical Devices median 26.7 · 1.17× the Medical Devices median
- Price / sales
- 5.80
Price / sales · today's price, trailing year to Sep 30, 2026
- Free cash flow yield
- 3.7%
Free cash flow yield · Medical Devices median 3.7%
- Growth the price implies
- +9.6%
Growth the price implies · The price pays for +9.6% free cash flow growth a year for a decade; the business has delivered +30% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Sep 30, 2026
- 11.7
- EV / EBITtoday's price, trailing year to Sep 30, 2026
- 23.4
- EV / salestoday's price, trailing year to Sep 30, 2026
- 5.62
- Healthcare median P/E497 names
- 27.1
- Medical Devices median P/E63 names
- 26.7
- Free cash flow, trailing twelve months
- $1.10B
- Market capitalisation373.0 million shares, counted Oct 22, 2026
- $29.6B
- 3-year revenue growth
- +14%
- 3-year free cash flow growth
- +30%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Medical Devices
The closest names by size in the same industry